Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial.

[1]  Thomas E. Moritz,et al.  Coronary-artery revascularization before elective major vascular surgery. , 2004, The New England journal of medicine.

[2]  H. Shikata,et al.  Long Term Outcome of Femoropopliteal Bypass for Claudication and Critical Ischemia , 2004, Asian cardiovascular & thoracic annals.

[3]  G. Coppola,et al.  Critical limb ischemia: definition and natural history. , 2004, Current drug targets. Cardiovascular & haematological disorders.

[4]  E. Lesho,et al.  Management of peripheral arterial disease. , 2004, American family physician.

[5]  S. Mondillo,et al.  Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. , 2003, The American journal of medicine.

[6]  P. Libby,et al.  Mechanisms of plaque stabilization with statins. , 2003, The American journal of cardiology.

[7]  W. Krupski.  Update on perioperative evaluation and management of cardiac disease in vascular surgery patients. , 2002, Journal of vascular surgery.

[8]  L. Goldman,et al.  beta-Blockers and reduction of cardiac events in noncardiac surgery: clinical applications. , 2002, JAMA.

[9]  G. Moneta,et al.  Vascular surgery for peripheral arterial disease. , 2002, Clinical cornerstone.

[10]  K. Ouriel.  Peripheral arterial disease , 2001, The Lancet.

[11]  A. Newman,et al.  EPIDEMIOLOGIC DATA IN CLINICAL PRACTICE , 2000 .

[12]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.

[13]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[14]  D. Waters,et al.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. , 1999, The New England journal of medicine.

[15]  G. Moneta,et al.  Reducing perioperative myocardial infarction following vascular surgery. The potential role of beta-blockade. , 1995, Archives of surgery.

[16]  L. Reilly,et al.  Comparison of cardiac morbidity rates between aortic and infrainguinal operations: two-year follow-up. Study of Perioperative Ischemia Research Group. , 1993, Journal of vascular surgery.

[17]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[18]  L. Reilly,et al.  Comparison of cardiac morbidity between aortic and infrainguinal operations. Study of Perioperative Ischemia (SPI) Research Group. , 1992, Journal of vascular surgery.

[19]  G. Moneta,et al.  The incidence of perioperative myocardial infarction in general vascular surgery. , 1992, Journal of vascular surgery.

[20]  L. Taylor,et al.  Clinical and Anatomic Considerations for Surgery in Femoropopliteal Disease and the Results of Surgery , 1991, Circulation.

[21]  S. A. Saleh,et al.  Aortoiliac occlusive disease: factors influencing survival and function following reconstructive operation over a twenty-five-year period. , 1981, Surgery.

[22]  H. Rifkin,et al.  Progress in Limb Saivage by Reconstructive Arterial Surgery Combined with New or Improved Adjunctive Procedures , 1981, Annals of surgery.